Search results for " oligos"

Article Transformative Medicines Challenge FDA and Manufacturers
Transformative Medicines Challenge FDA and Manufacturers New gene therapies and combination products require innovative regulatory approaches. By Jill Wechsler …

Article Evolving demands of process development services
And, more recently, there has been a high demand for the CDMOs that can handle oligos, peptides, and various complex conjugates. Novel conjugates involving combinations of oligos, peptides, high poten…

Article Enhancing Resins Addresses Purification Concerns
Now, we start to see a new landscape based on a variety of new modalities such as viral vectors, mRNA, pDNA, cell and gene therapy, and oligos,” he adds. Ihre notes that a common feature of …

Article Working With Advanced Therapeutics: You Bring the Idea, We Bring the Map
Plasmids. mRNA. Oligos. Cell and gene therapies. Antibody variants. Vaccines. We all know these advanced therapies hold huge potential. But developing them isn’t straightforward, and fai…

Multimedia Q&A: Oligonucleotide synthesis in process development and scale-up
In this video, Greg Farlow, RNA/DNA synthesis product specialist at Cytiva, talks about the typical challenges with oligonucleotide synthesis in process development and key considerations when scaling…

Article Q&A: Oligonucleotide synthesis in process development and scale-up
Farlow In this video, Greg Farlow, RNA/DNA synthesis product specialist at Cytiva, talks about the typical challenges with oligonucleotide synthesis in process development and key cons…

Article Navigating Molecular Diversity
Are you working with biomolecules beyond mAbs? Read more here >>

Article Improving the Oligonucleotide Synthesis Experience
We often hear from scientists working with oligonucleotide synthesis that the technical complexity of the process can be a roadblock for some users. Addressing this challenge was one of Cytiva…

Article Oligonucleotide Development and Manufacturing Workflow
Click here to view >> Learn more on key considerations when setting up an oligonucleotide workflow with this infographic.

Article Key Process Considerations for Therapeutic Oligonucleotides
Click here to read the article >> Learn more about scalable solutions for developing and manufacturing oligonucleotide therapeutics.

Next Page